Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3Completed 3Unknown 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Social Isolation 1Ovarian Neoplasms 1Lung Neoplasms 1Depression 1Communication 1Anxiety Disorders 1

Interventions

pembrolizumab 551Specimen Handling 465Carboplatin 441Magnetic Resonance Spectroscopy 430Cyclophosphamide 412Cisplatin 397Radiotherapy 313Gemcitabine 309Bevacizumab 307Paclitaxel 294Biopsy 261Drug Therapy 249Capecitabine 242Oxaliplatin 239fludarabine 237Nivolumab 224venetoclax 219Injections 213Docetaxel 205Fluorouracil 203Dexamethasone 187Radiosurgery 172Rituximab 158Pemetrexed 153Standard of Care 146durvalumab 143Leucovorin 139atezolizumab 138toripalimab 134tislelizumab 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Interventional × Artificial Intelligence × Clear all
NCT07454460 2026-05-22

AYA-PeerConnect: A Communication Coaching Intervention for Adolescent/Young Adult Cancer Survivors (AYACS)

Milton S. Hershey Medical Center

Phase NA Recruiting
10 enrolled

Anxiety Disorders, Communication, Depression, Social Isolation

NCT07458425 2026-04-06

The SENTINL-1 Study: Evaluating Patient-Reported Outcomes of AI-Inferred Lung Cancer Risk

University of Illinois at Chicago

Phase NA Recruiting
400 enrolled
Thoracic

Lung Neoplasms

NCT06017557 2025-12-19

PREDAtOOR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Recruiting
151 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡